Unlocking Growth: How Digital Innovation is T...

Join Tom Lehmann and Petra Jantzer, Accenture's Global Life Sciences Lead, as they cover the highlights of 2025 and look forward to 2026. What's coming next for biopharma? Tune in for the trends and insights that will shape the future. 

Join Roy Helmy, Associate VP at Merck, as he explores what it takes to reinvent the lab from the ground up. From AI to end-to-end digital transformation of lab operations, Roy shares actionable insights on overcoming resistance and fostering collaboration, and why learning from f ...  Show more

In this episode, Clemens Utschig-Utschig, CTO at Boehringer Ingelheim, guides us through the digital and technological transformation of a 140-year-old family-owned pharmaceutical company. Explore how he utilizes data and technology to revolutionize drug development and personali ...  Show more

"Pharmaceutical Breakthroughs: The Cutting Edge of Biotechnology" - In this episode, we dive deep into the revolutionary world of biotechnology and its transformative impact on pharmaceuticals. Discover how cutting-edge innovations are reshaping drug development, accelerating vac ...  Show more

View the Show Notes Page for This Episode

<a href= "https://petera ...

Bringing new drugs to market is a costly, time-consuming endeavor. On top of that, most medicines fail at some point in the research and development phase. Sarah Guo is joined by Sajith Wickramasekara, co-founder and CEO of Benchling, a company that has not only become the centra ...  Show more